Chugai Pharmaceutical Co (CUP) Stock Statistics & Valuation Metrics

Chugai Pharmaceutical Co has a market cap or net worth of EUR 63.59B. The enterprise value is EUR 9.39T.

Market Cap

EUR 63.59B

Enterprise Value

EUR 9.39T

Chugai Pharmaceutical Co has 1,679,057,600 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

1,679,057,600

Owned by Insiders

―

Owned by Institutions

10.70%

Chugai Pharmaceutical Co’s return on equity (ROE) is 0.21 and return on invested capital (ROIC) is 20.83%.

Return on Equity (ROE)

0.21

Return on Assets (ROA)

0.18

Return on Invested Capital (ROIC)

20.83%

Return on Capital Employed (ROCE)

0.29

Revenue Per Employee

246.46M

Profits Per Employee

85.03M

Employee Count

5,104

Asset Turnover

0.51

Inventory Turnover

1.31

The current PE Ratio of Chugai Pharmaceutical Co is 22.29. Chugai Pharmaceutical Co’s PEG ratio is 0.83.

PE Ratio

22.29

PS Ratio

7.94

PB Ratio

5.38

Price to FCF

30.90

Price to Operating Cash Flow

25.59

PEG Ratio

0.83

In the last 12 months, Chugai Pharmaceutical Co had revenue of 1.26T and earned 434.01B in profits. Earnings per share was 263.73.

Revenue

1.26T

Gross Profit

894.25B

Operating Income

590.19B

Pretax Income

597.81B

Net Income

434.01B

EBITDA

631.37B

Earnings Per Share (EPS)

263.73

In the last 12 months, operating cash flow was 438.72B and capital expenditures -75.47B, giving a free cash flow of 363.25B billion.

Operating Cash Flow

438.72B

Free Cash Flow

363.25B

Free Cash Flow per Share

220.74

Chugai Pharmaceutical Co pays an annual dividend of ―, resulting in a dividend yield of 3.14%

Dividend Per Share

―

Dividend Yield

3.14%

Payout Ratio

N/A

Free Cash Flow Yield

3.24%

Earnings Yield

4.49%

Beta

0.68

52-Week Price Change

1.40%

50-Day Moving Average

36.10

200-Day Moving Average

41.87

Relative Strength Index (RSI)

63.17

Average Volume (3m)

72

Chugai Pharmaceutical Co upcoming earnings date is Feb 04, 2027, TBA (Not Confirmed).

Last Earnings Date

Oct 27, 2026

Next Earnings Date

Feb 04, 2027

Ex-Dividend Date

―

Chugai Pharmaceutical Co as a current ratio of 4.23, with Debt / Equity ratio of 0.00%

Current Ratio

4.23

Quick Ratio

3.56

Debt to Market Cap

0.00

Net Debt to EBITDA

-0.68

Interest Coverage Ratio

575.24

In the past 12 months, Chugai Pharmaceutical Co has paid 163.79B in taxes.

Income Tax

163.79B

Effective Tax Rate

0.27

Chugai Pharmaceutical Co EV to EBITDA ratio is 15.39, with an EV/FCF ratio of 29.90.

EV to Sales

7.68

EV to EBITDA

15.39

EV to Free Cash Flow

29.90

EV to Operating Cash Flow

24.75

Chugai Pharmaceutical Co has EUR 869.00B in cash and marketable securities with EUR 16.14B in debt, giving a net cash position of EUR 852.85B billion.

Cash & Marketable Securities

EUR 869.00B

Total Debt

EUR 16.14B

Net Cash

EUR 852.85B

Net Cash Per Share

EUR 507.93

Tangible Book Value Per Share

EUR 1,233.36

Gross margin is 71.50%, with operating margin of 46.53%, and net profit margin of 35.61%.

Gross Margin

71.50%

Operating Margin

46.53%

Pretax Margin

49.76%

Net Profit Margin

35.61%

EBITDA Margin

49.90%

EBIT Margin

48.44%

The average price target for Chugai Pharmaceutical Co is EUR 45.89, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target

EUR 45.89

Price Target Upside

19.48% Upside

Analyst Consensus

Moderate Buy

Analyst Count

11

Revenue Growth Forecast

5.11%

EPS Growth Forecast

14.47%